Search
forResearch 10 of 1000+
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
- Estrogen deprivation effects of endocrine therapy in breast cancer patients: Incidence, management and outcome
- Clinical aspect, pathogenesis and therapy options of alopecia induced by hormonal therapy for breast cancer
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Integration of biological and psychological factors in horticultural therapy for cancer patients: focused on making grass dolls, transplanting, and making tea with herb plants
- INDIVIDUAL ARTICLE: USCOM V: A Practical Algorithm for the Prevention and Treatment of Cutaneous Side Effects of Hormonal Cancer Therapy
- Survey on adverse events associated with drug therapy for breast cancer patients
- Cardiovascular effects of hormone therapy for prostate cancer
- THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?
Community 10 of 49
- How soon is hair clone? Next five years?!
- Why is it "not right" to start off with Dutasteride?
- 0.5mg Dutasteride promotes more “regrowth” than 5mg oral Minoxidil
- Sunlight: Does it Stimulate Hair Growth or Hair Loss?
- Expectations control for SCUBE3
- M29 - 4 YEARS on Dutasteride - almost no progress
- They’re curing cancer before solving baldness
- Does RU58841 potentially cause cancer?
- Cancer took my hair 3 times. Trying to get it back!
- Pattern hair loss before the age of 35 is associated with higher chances of prostate cancer, cardiovascular diseases, and metabolic syndrome later in life